Rankings
▼
Calendar
HRTX FY 2006 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HRTX
Heron Therapeutics, Inc.
$147M
FY 2006 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
Gross Profit
$0
0.0% margin
Operating Income
-$19M
-349.9% margin
Net Income
$5M
97.7% margin
EPS (Diluted)
$66.25
Cash Flow
Operating Cash Flow
$9M
Free Cash Flow
$9M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$17M
Total Liabilities
$5M
Stockholders' Equity
$12M
Cash & Equivalents
$2M
← FY 2007
All Quarters